Delivery Order SPE2DB20D3101-SPE2DB23FRST3
Award Date
7/26/23
Potential Completion Date
7/27/23
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of febuxostat 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,075.98 and an ultimate completion date of April 14, 2025. There was no set-aside designation for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $2,279.77, is a firm fixed price delivery order for the supply of Febuxostat 80mg tablets. The award has no set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,119,086 units of Febuxostat 40 mg tablets. The $2,347.52 firm fixed-price contract has an ultimate completion date of August 17, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,611.32 Firm Fixed Price delivery order is for the delivery of 4562163921 - Febuxostat 80 mg Tablets, 30s. The contract has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The federal contract award, SPE2DB20D3505|SPE2DB22FT9R2, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.59 delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2022. This award is associated with Amerisourcebergen's...
This federal contract award is for the delivery of Febuxostat 40 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,190.89, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure and has an ultimate completion date of January 22, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of Febuxostat 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,507.50 and runs through September 11, 2023. It is a firm fixed-price delivery order contract, indicating a specific quantity of the medication is being purchased. The contract was not set aside for any...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 80 mg tablets. The $1,328.20 firm fixed-price award has a period of performance through July 2024. Amerisourcebergen provides a wide range of essential pharmaceutical and medical products to federal agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,883.24, is for the delivery of 4,567,985,060 units of Febuxostat 40 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,358.43 firm fixed-price delivery order is for the supply of 4559470354 - Febuxostat 40 mg Tablets, 30s. The award has an ultimate completion date of December 30, 2022 and was made on December 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...